High Court bans 34 pharmaceutical companies from producing medicines
Staff Correspondent, bdnews24.com
Published: 2017-02-13 14:47:07.0 BdST Updated: 2017-02-14 02:15:50.0 BdST
Twenty pharmaceutical companies have been banned from producing all medicines and 14 others from producing antibiotics by the High Court.
The order on Monday by Justices Syed Mohammed Dastagir and Ataur Rahman Khan came after hearing of a rule issued earlier on a petition filed by the Human Rights and Peace for Bangladesh (HRPB) to stop production and marketing of substandard medicines.
The order asked the Bangladesh drug regulatory authority to regularly monitor whether these companies continued to produce and market medicines and file a report to the High Court after every four months.
HRPB counsel Manzill Murshid said that the government has already cancelled the license of 7-8 of these 34 companies.
The High Court has constituted a five-member committee to examine fresh application by those companies who have not had their license cancelled, if they agreed to abide by existing drug regulatory parameters.
The committee consists of a representative each from World Health Organisation, Bangladesh Drug Regulatory Authority, Dhaka University's Pharmacy department and the Health Ministry.
Twenty companies banned from producing all medicines
Exim Pharmaceuticals, Avert Pharma Ltd, Bikalpa Pharmaceuticals Ltd, Dolphin Pharmaceuticals Ltd, Drugland Ltd, Globe Laboratories Pvt Ltd, Jolpa Laboratories Ltd, Kafma Pharmaceuticals Ltd, Medico Pharmaceuticals Ltd, National Drug Pharma Ltd, North Bengal Pharmaceuticals Ltd, Rimo Chemicals Ltd, Rid Pharmaceuticals Ltd, Skylab Pharmaceuticals Ltd, Spark Pharmaceuticals Ltd, Star Pharmaceuticals Ltd, Shunipun Pharmaceuticals Ltd, Today Pharmaceuticals Ltd, Tropical Pharmaceuticals Ltd and Universal Pharmaceuticals Ltd
Fourteen companies banned from producing antibiotics
Ad-dwin Pharmaceutical Ltd, Alkad Laboratories Ltd, Belsen Pharmaceuticals Ltd, Bengal Drugs and Chemicals (Pharma) Ltd, Bristol Pharma Ltd, Crystal Pharmaceuticals Ltd, Indo-Bangla Pharmaceuticals Ltd, Millat Pharmaceuticals Ltd, MST Pharma and Healthcare Ltd, Orbit Pharmaceuticals Ltd, Pharmic Laboratories ltd, Phoenix Chemical Laboratory Ltd, Rasa Pharmaceuticals Ltd and Save Pharmaceuticals Ltd
Any unauthorised use or reproduction of bdnews24.com content for commercial purposes is strictly prohibited and constitutes copyright infringement liable to legal action.
- China wants ‘solid effort’ to address difficulties in doing business in Bangladesh
- First cargo ship from India arrives at Pangaon in Dhaka
- Kraft Heinz bids $143 billion for Unilever in global brand grab
- Striking meat traders to meet commerce minister, city corporation officials Sunday
- Samsung chief Lee arrested in corruption investigation
- High commissioner says Bangladesh now India's biggest trade partner in South Asia
- Newspapers aim to ride 'Trump Bump' to reach readers, advertisers
- 'Little hope' for textile industry revival in 'struggling' Nigeria
- Hong Kong police struggle to stop brokerage hacking spree
- Indo-Bangla trade fair begins in Dhaka Thursday
- Minister Quader was 'just angry', says MP Sanowar claiming reports of being assaulted not true
- New US travel ban to spare green card holders: Trump official
- Trump administration to expand groups of immigrants to be deported: Documents
- Director Farooki's "Doob: No Bed of Roses" stalled
- PM Hasina stops over at Abu Dhabi on way home from Munich
- Island chosen to relocate Rohingya refugees not fit for habitation, says Bangladesh forest department
- Bangladesh court to deliver verdict in Japanese national Kunio Hoshi murder on Feb 28
- Graphic novel 'Mujib' part-3 to be released Sunday
- PM’s meeting with Merkel: Global support to relocate Rohingya refugees sought
- Man dies in ‘gunfight’ with RAB in Rajshahi